Roy A. Jensen
Affiliations: | University of Kansas, Lawrence, KS, United States |
Website:
http://www.kumc.edu/school-of-medicine/pathology/faculty-and-staff/basic-science-faculty/roy-a-jensen-md.htmlGoogle:
"Roy Jensen"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Standing D, Dandawate P, Gunewardena S, et al. (2024) Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer. Cell Death & Disease. 15: 362 |
| Jensen RA, Befort CA. (2023) Cancer Prevention Perspective: The University of Kansas Cancer Center. Cancer Prevention Research (Philadelphia, Pa.). 16: 643-647 |
| Li L, Jensen RA. (2023) Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells. Cancer Research. 83: 2096-2104 |
| Cloud AS, Vargheese AM, Gunewardena S, et al. (2022) Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression. Bmc Cancer. 22: 180 |
| Bhatti S, Heldstab J, Lehn C, et al. (2022) Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis. Jco Precision Oncology. 1: 1-6 |
| Subramaniam D, Ponnurangam S, Ramalingam S, et al. (2021) Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Cells. 10 |
| Ramamoorthy P, Dandawate P, Jensen RA, et al. (2021) Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells. Biomedicines. 9 |
| Mudaranthakam DP, Harlan-Williams LM, Jensen RA, et al. (2020) OPTIK: a database for understanding catchment areas to guide mobilization of cancer center assets. Database : the Journal of Biological Databases and Curation. 2020 |
| Dandawate P, Subramaniam D, Panovich P, et al. (2020) Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Scientific Reports. 10: 1290 |
| Jensen RA, Knudsen KE, Platanias LC. (2020) Disclose and Manage Conflicts of Interest at Cancer Centers. Jama Internal Medicine. 180: 161 |